FY2025 EPS Estimates for DRUG Boosted by Cantor Fitzgerald
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Free Report) – Equities researchers at Cantor Fitzgerald boosted their FY2025 earnings estimates for shares of Bright Minds Biosciences in a research note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst P. Stavropoulos now anticipates that the company will post earnings per share of ($0.64) for the […]
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Free Report) – Equities researchers at Cantor Fitzgerald boosted their FY2025 earnings estimates for shares of Bright Minds Biosciences in a research note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst P. Stavropoulos now anticipates that the company will post earnings per share of ($0.64) for the […]
